e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Severe acute asthma and troublesome wheezing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review
R. Austin (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom)
Source:
International Congress 2019 – Severe acute asthma and troublesome wheezing
Session:
Severe acute asthma and troublesome wheezing
Session type:
Thematic Poster
Number:
960
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Austin (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom). Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review. 960
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Adverse childhood experience and asthma onset: a systematic review
Source: Eur Respir Rev 2015; 24: 299-305
Year: 2015
Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis
Source: Eur Respir J, 50 (5) 1701153; 10.1183/13993003.01153-2017
Year: 2017
Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021
Association between COPD exacerbations and acute cardiovascular events: a systematic literature review
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations)
Source: Eur Respir J 2007; 30: Suppl. 51, 125s
Year: 2007
Medication adherence and the risk of severe asthma exacerbations: a systematic review
Source: Eur Respir J 2015; 45: 396-407
Year: 2015
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018
QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β
2
-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009
Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016
Year: 2017
Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
The burden of exacerbations in mild asthma: a systematic review
Source: ERJ Open Res, 6 (3) 00359-2019; 10.1183/23120541.00359-2019
Year: 2020
Premature discontinuation of patients: a potential bias in COPD clinical trials
Source: Eur Respir J 2007; 30: 898-906
Year: 2007
The association between adherence and outcomes in severe asthma: a systematic review
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept